Cohen R, Buchsenschutz B, Estrade P, Gardet P, Modigliani E
Service d'Endocrinologie, Hôpital Avicenne-Université Paris XIII, Bobigny.
Presse Med. 1996 Nov 30;25(37):1819-22.
Medullary thyroid carcinoma (MTC) is characterized by different clinical forms and a possible prolonged survival, despite presence of metastases. In the present study, we have studied the clinical and biological characteristics of 119 decreased MTC patients.
Our data were retrieved retrospectively from the French medullary thyroid cancer study group (GETC).
Our results showed that the cause of death was basically MTC (87%) but not exclusively, depending on the clinical forms and the age. Patients with type IIb multiple endocrine meoplasia (MEN) died earlier from their carcinoma. Patients with type IIa MEN died of causes other than MTC, especially pheochromocytoma. Two-thirds of the patients with sporadic forms of MTC, died with advanced metastases, usually from MTC.
A significant number of deaths in patients with medullary thyroid carcinoma result from non-cancerous causes. This study established the clinical and biological characteristics of patients at risk of death.
甲状腺髓样癌(MTC)具有不同的临床形式,尽管存在转移,仍可能有较长生存期。在本研究中,我们研究了119例晚期MTC患者的临床和生物学特征。
我们的数据是从法国甲状腺髓样癌研究组(GETC)回顾性获取的。
我们的结果表明,死亡原因主要是MTC(87%),但并不唯一,这取决于临床形式和年龄。IIb型多发性内分泌肿瘤(MEN)患者死于其癌症的时间更早。IIa型MEN患者死于MTC以外的原因,尤其是嗜铬细胞瘤。三分之二散发型MTC患者死于晚期转移,通常是死于MTC。
相当数量的甲状腺髓样癌患者死于非癌症原因。本研究确定了有死亡风险患者的临床和生物学特征。